-
1
-
-
84988635370
-
-
International Agency for Research on Cancer [http://globocan.iarc.fr/Pages/ fact_sheets_cancer.aspx]
-
-
-
-
2
-
-
61749103821
-
Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells
-
Choi EJ, Kim GH: Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. J Nutr Biochem 2009, 20:285-290.
-
(2009)
J Nutr Biochem
, vol.20
, pp. 285-290
-
-
Choi, E.J.1
Kim, G.H.2
-
3
-
-
34248195589
-
Tumors initiate by constructive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression
-
Corsino P, Davis B, Law M, Chytil A, Forrester E, Nrgaard P, Teoh N, Law B: Tumors initiate by constructive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Cancer Res 2007, 67:3135-3144.
-
(2007)
Cancer Res
, vol.67
, pp. 3135-3144
-
-
Corsino, P.1
Davis, B.2
Law, M.3
Chytil, A.4
Forrester, E.5
Nrgaard, P.6
Teoh, N.7
Law, B.8
-
4
-
-
65949113600
-
Low molecularweight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression
-
Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K: Low molecularweight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle 2009, 8:1062-1068.
-
(2009)
Cell Cycle
, vol.8
, pp. 1062-1068
-
-
Wingate, H.1
Puskas, A.2
Duong, M.3
Bui, T.4
Richardson, D.5
Liu, Y.6
Tucker, S.L.7
Van Pelt, C.8
Meijer, L.9
Hunt, K.10
Keyomarsi, K.11
-
5
-
-
76749155560
-
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors
-
Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K: Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res 2010, 16:1179-1190.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1179-1190
-
-
Akli, S.1
Bui, T.2
Wingate, H.3
Biernacka, A.4
Moulder, S.5
Tucker, S.L.6
Hunt, K.K.7
Keyomarsi, K.8
-
6
-
-
79955490608
-
Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E
-
Akli S, Van Pelt CS, Bui T, Meijer L, Keyomarsi K: Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E. Cancer Res 2011, 71:3377-3386.
-
(2011)
Cancer Res
, vol.71
, pp. 3377-3386
-
-
Akli, S.1
Van Pelt, C.S.2
Bui, T.3
Meijer, L.4
Keyomarsi, K.5
-
7
-
-
68049125103
-
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity
-
Ali S, Heathcote DA, Kroll SH, Jogalekar AS, Scheiper B, Patel H, Brackow J, Siwicka A, Fuchter MJ, Periyasamy M, Tolhurst RS, Kanneganti SK, Snyder JP, Liotta DC, Aboagye EO, Barrett AG, Coombes RC: The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res 2009, 69:6208-6215.
-
(2009)
Cancer Res
, vol.69
, pp. 6208-6215
-
-
Ali, S.1
Heathcote, D.A.2
Kroll, S.H.3
Jogalekar, A.S.4
Scheiper, B.5
Patel, H.6
Brackow, J.7
Siwicka, A.8
Fuchter, M.J.9
Periyasamy, M.10
Tolhurst, R.S.11
Kanneganti, S.K.12
Snyder, J.P.13
Liotta, D.C.14
Aboagye, E.O.15
Barrett, A.G.16
Coombes, R.C.17
-
8
-
-
79951807772
-
Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-positive breast cancer cells
-
Wesierska-Gadek J, Gritsch D, Zulehner N, Komina O, Maurer M: Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-positive breast cancer cells. J Cell Biochem 2011, 112:761-772.
-
(2011)
J Cell Biochem
, vol.112
, pp. 761-772
-
-
Wesierska-Gadek, J.1
Gritsch, D.2
Zulehner, N.3
Komina, O.4
Maurer, M.5
-
9
-
-
75549090821
-
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
-
Johnson N, Bentley J, Wang LZ, Newell DR, Robson CN, Shapiro GI, Curtin NJ: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. Br J Cancer 2010, 102:342-350.
-
(2010)
Br J Cancer
, vol.102
, pp. 342-350
-
-
Johnson, N.1
Bentley, J.2
Wang, L.Z.3
Newell, D.R.4
Robson, C.N.5
Shapiro, G.I.6
Curtin, N.J.7
-
10
-
-
0028864747
-
Deleted in oral cancer-q (doc-1), a novel oral tumor suppressor gene
-
Todd R, McBride J, Tsuji T, Donoff RB, Nagai M, Chou MY, Chiang T, Wong DT: Deleted in oral cancer-q (doc-1), a novel oral tumor suppressor gene. FASEB J 1995, 9:1362-1370.
-
(1995)
FASEB J
, vol.9
, pp. 1362-1370
-
-
Todd, R.1
McBride, J.2
Tsuji, T.3
Donoff, R.B.4
Nagai, M.5
Chou, M.Y.6
Chiang, T.7
Wong, D.T.8
-
11
-
-
15544391299
-
Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1
-
Tsuji T, Duh FM, Latif F, Popescu NC, Zimonjic DB, McBride J, Matsuo K, Ohyama H, Todd R, Nagata E, Terakado N, Sasaki A, Matsumura T, Lerman MI, Wong DT: Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem 1998, 271:6704-6709.
-
(1998)
J Biol Chem
, vol.271
, pp. 6704-6709
-
-
Tsuji, T.1
Duh, F.M.2
Latif, F.3
Popescu, N.C.4
Zimonjic, D.B.5
McBride, J.6
Matsuo, K.7
Ohyama, H.8
Todd, R.9
Nagata, E.10
Terakado, N.11
Sasaki, A.12
Matsumura, T.13
Lerman, M.I.14
Wong, D.T.15
-
12
-
-
1642475176
-
Role of p12 (CDK2-AP1) in transforming growth factor beta 1 mediated growth suppression
-
Hu MG, Hu GF, Kim Y, Tsuji T, McBride J, Hinds P, Wong DT: Role of p12 (CDK2-AP1) in transforming growth factor beta 1 mediated growth suppression. Cancer Res 2004, 64:490-499.
-
(2004)
Cancer Res
, vol.64
, pp. 490-499
-
-
Hu, M.G.1
Hu, G.F.2
Kim, Y.3
Tsuji, T.4
McBride, J.5
Hinds, P.6
Wong, D.T.7
-
13
-
-
33845595885
-
Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad sigaling pathway
-
Peng H, Shintani S, Kim Y, Wong DT: Loss of p12CDK2-AP1 expression in human oral squamous cell carcinoma with disrupted transforming growth factor-beta-Smad sigaling pathway. Neoplasia 2006, 8:1028-1036.
-
(2006)
Neoplasia
, vol.8
, pp. 1028-1036
-
-
Peng, H.1
Shintani, S.2
Kim, Y.3
Wong, D.T.4
-
14
-
-
13244266955
-
P12(CDK2-AP1) mediates DNA damage responses induced by cisplatin
-
Kim Y, McBride J, Zhang R, Zhou X, Wong DT: P12(CDK2-AP1) mediates DNA damage responses induced by cisplatin. Oncogene 2005, 24:407-418.
-
(2005)
Oncogene
, vol.24
, pp. 407-418
-
-
Kim, Y.1
McBride, J.2
Zhang, R.3
Zhou, X.4
Wong, D.T.5
-
15
-
-
61849170565
-
Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues
-
Choi MG, Sohn TS, Park SB, Paik YH, Noh JH, Kim KM, Park CK, Kim S: Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues. Eur Surg Res 2009, 42:223-229.
-
(2009)
Eur Surg Res
, vol.42
, pp. 223-229
-
-
Choi, M.G.1
Sohn, T.S.2
Park, S.B.3
Paik, Y.H.4
Noh, J.H.5
Kim, K.M.6
Park, C.K.7
Kim, S.8
-
16
-
-
68249158574
-
p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma
-
Hiyoshi Y, Watanabe M, Hirashima K, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Baba H: p12CDK2-AP1 is associated with tumor progression and a poor prognosis in esophageal squamous cell carcinoma. Oncol Rep 2009, 22:35-39.
-
(2009)
Oncol Rep
, vol.22
, pp. 35-39
-
-
Hiyoshi, Y.1
Watanabe, M.2
Hirashima, K.3
Karashima, R.4
Sato, N.5
Imamura, Y.6
Nagai, Y.7
Yoshida, N.8
Toyama, E.9
Hayashi, N.10
Baba, H.11
-
17
-
-
69449084550
-
Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function
-
Zolochevska O, Figueiredo ML: Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function. Prostate 2009, 69:1586-1597.
-
(2009)
Prostate
, vol.69
, pp. 1586-1597
-
-
Zolochevska, O.1
Figueiredo, M.L.2
-
18
-
-
84871307708
-
p12CDK2-AP1 inhibits breast cancer cell proliferation and in vivo tumor growth
-
Zhou W, Guan X, Wang L, Liao Y, Huang J: p12CDK2-AP1 inhibits breast cancer cell proliferation and in vivo tumor growth. J Cancer Res Clin Oncol 2012, 138:2085-2093.
-
(2012)
J Cancer Res Clin Oncol
, vol.138
, pp. 2085-2093
-
-
Zhou, W.1
Guan, X.2
Wang, L.3
Liao, Y.4
Huang, J.5
|